Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.

被引：0
|
作者：
Bachier, C
Shaughnessy, P
Wall, D
Grimley, M
Carrum, G
Freytes, C
Callander, N
Walsh, T
LeMaistre, CF
机构：
[1] Texas Transplant Inst, San Antonio, TX USA
[2] Baylor Coll Med, Methodist Hosp, Ctr Cellular & Gene Therapy, Houston, TX USA
[3] Univ Texas, Ctr Hlth Sci, Dept Med, San Antonio, TX USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5074
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [1] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
  • [2] Cidofovir for cytomegalovirus (CMV) antigenemia after allogeneic stem cell transplantation.
    Soligo, D
    Tagliaferri, E
    Barraco, F
    Lambertenghi, D
    Della Volpe, A
    Deliliers, GL
    [J]. BLOOD, 1998, 92 (10) : 339B - 339B
  • [3] Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.
    Magalhaes-Silverma, Margarida
    Parrott, Karen
    Carter, Thomas
    Leopold, Christina
    Raymond, Hohl
    Roger, Gingrich
    [J]. BLOOD, 2006, 108 (11) : 807A - 807A
  • [4] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [5] Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)
    Aberle, MF
    Bachier, C
    Lemaistre, FC
    Shaughnessy, PJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 136 - 136
  • [6] Valganciclovir is safe and effective as pre-emptive treatment for CMV infection in allogeneic hematopoietic stem cell transplantation.
    Pastano, Rocco
    Gigli, Federica
    Andreola, Giovanna
    Calabrese, Liliana
    Peccatori, Fedro
    Martinelli, Giovanni
    [J]. BLOOD, 2006, 108 (11) : 417B - 417B
  • [7] Immunosuppressive effect of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Giebel, S
    Maccario, R
    Avanzini, MA
    Marconi, M
    Rossi, G
    Gentile, R
    Travaglino, P
    Locatelli, F
    [J]. BLOOD, 2003, 102 (11) : 973A - 973A
  • [8] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [9] Efficacy of prophylaxis on cytomegalovirus infection after allogeneic hematopoietic progenitor transplantation.
    de la Banda, E
    Ferra, C
    Perez, JL
    Berlanga, JJ
    Gallardo, D
    Sarra, J
    Granena, A
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S141 - S141
  • [10] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
12345